News from the
Inaugural EURETINA Innovation Spotlight (EIS)

Retina specialists who have innovative ideas for new therapies and devices heard encouraging words from panellists participating in the “Investing in Retina” session at the EURETINA Innovation Spotlight. Representing European- and US-based venture capital firms that provide financing for research and development of entities that may be just a new...

Evidence of burgeoning research to develop new medical therapeutics for retinal diseases was strong at the EURETINA Innovation Spotlight (EIS) where two 75-minute sessions were devoted to innovation in medical therapy. During the dual sessions, speakers representing 13 companies took to the podium to showcase their company’s pipeline, and panel...

The Inaugural EURETINA Innovation Spotlight (EIS) held on October 4th, 2023 brought together the stakeholders involved in the development of the next generation innovative retinal therapies and diagnostics. In launching this new event, the goal of EURETINA was to create and foster communication and collaboration to advance and improve the...